Grifols Shares Outstanding:
555.96M for March 31, 2013Grifols Historical Shares Outstanding Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 555.96M |
| Dec. 31, 2012 | 545.30M |
| Sept. 30, 2012 | 545.30M |
| June 30, 2012 | 545.30M |
| March 31, 2012 | 545.30M |
| Dec. 31, 2011 | 545.30M |
| Sept. 30, 2011 | 545.30M |
| June 30, 2011 | 514.13M |
About Shares Outstanding
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares outstanding represents a company's market value spread across the amount of shares outstanding. The amount of shares outstanding is frequently used in ratios such as Earnings Per Share.
Learn More
GRFS Shares Outstanding Benchmarks
| Companies | |
|---|---|
| Cadence Pharmaceuticals | 85.80M |
| ARCA biopharma | 3.186M |
| Sangamo BioSciences | 53.35M |
GRFS Shares Outstanding Range, Past 5 Years
| Minimum | 514.13M | Jun 30 2011 |
| Maximum | 555.96M | Mar 31 2013 |
| Average | 542.74M |
